Literature DB >> 2170883

Alpha 2-adrenergic mechanism in menopausal hot flushes.

R R Freedman1, S Woodward, S C Sabharwal.   

Abstract

It has been hypothesized that hot flushes are triggered within the hypothalamus by alpha 2-adrenergic receptors on noradrenergic neurons. We administered intravenous clonidine (an alpha 2-adrenergic agonist) and yohimbine (an alpha 2-adrenergic antagonist) to nine menopausal women with hot flushes and to an asymptomatic comparison group. Hot flushes were defined objectively by skin conductance responses recorded from the sternum; finger temperature recordings and symptom reports were also evaluated. The subjects were prescreened using ambulatory skin conductance monitoring. A significantly greater number of hot flushes occurred during yohimbine sessions than in corresponding placebo sessions (six versus zero). Clonidine significantly increased the amount of peripheral heating needed to provoke a hot flush (40.6 versus 33.6 minutes) and reduced the number of hot flushes that did occur (two versus eight). No hot flushes occurred in the asymptomatic women. These findings support the role of a central alpha 2-adrenergic mechanism in the initiation of hot flushes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170883

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  24 in total

Review 1.  Mechanism of hot flashes.

Authors:  Santiago Vilar-González; Alberto Pérez-Rozos; Ruben Cabanillas-Farpón
Journal:  Clin Transl Oncol       Date:  2011-03       Impact factor: 3.405

2.  Tissue-selective estrogen complex bazedoxifene and conjugated estrogens for the treatment of menopausal vasomotor symptoms.

Authors:  Dale W Stovall; Kirby Tanner-Kurtz; JoAnn V Pinkerton
Journal:  Drugs       Date:  2011-09-10       Impact factor: 9.546

3.  Hot Flash Frequency and Blood Pressure: Data from the Study of Women's Health Across the Nation.

Authors:  Elizabeth A Jackson; Samar R El Khoudary; Sybil L Crawford; Karen Matthews; Hadine Joffe; Claudia Chae; Rebecca C Thurston
Journal:  J Womens Health (Larchmt)       Date:  2016-07-12       Impact factor: 2.681

4.  Changes in heart rate variability during vasomotor symptoms among midlife women.

Authors:  Rebecca C Thurston; Karen A Matthews; Yuefang Chang; Nanette Santoro; Emma Barinas-Mitchell; Roland von Känel; Doug P Landsittel; J Richard Jennings
Journal:  Menopause       Date:  2016-05       Impact factor: 2.953

Review 5.  Menopausal hot flashes: mechanisms, endocrinology, treatment.

Authors:  Robert R Freedman
Journal:  J Steroid Biochem Mol Biol       Date:  2013-09-04       Impact factor: 4.292

6.  Skin function and skin disorders in Parkinson's disease.

Authors:  M Fischer; I Gemende; W C Marsch; P A Fischer
Journal:  J Neural Transm (Vienna)       Date:  2001       Impact factor: 3.575

7.  Escitalopram treatment of menopausal hot flashes.

Authors:  Robert R Freedman; Michael L Kruger; Manuel E Tancer
Journal:  Menopause       Date:  2011-08       Impact factor: 2.953

8.  Anxiogenic CO2 stimulus elicits exacerbated hot flash-like responses in a rat menopause model and hot flashes in postmenopausal women.

Authors:  Lauren M Federici; Sarah Dorsey Roth; Connie Krier; Stephanie D Fitz; Todd Skaar; Anantha Shekhar; Janet S Carpenter; Philip L Johnson
Journal:  Menopause       Date:  2016-11       Impact factor: 2.953

Review 9.  Postmenopausal hormone therapy: impact on menopause-related symptoms, chronic disease and quality of life.

Authors:  Marius Jan van der Mooren; Peter Kenemans
Journal:  Drugs       Date:  2004       Impact factor: 9.546

10.  Hot flashes and cardiac vagal control: a link to cardiovascular risk?

Authors:  Rebecca C Thurston; Israel C Christie; Karen A Matthews
Journal:  Menopause       Date:  2010 May-Jun       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.